Insights

More Articles Back to Article

Japan approves Myriad's BRACAnalysis diagnostic system

Myriad Genetics has obtained approval from Japan's Ministry of Health, Labor and Welfare for its BRACAnalysis Diagnostic System, which is designed to identify breast cancer patients with germline mutations of BRCA1 and BRCA2. Patients may be recommended for prophylactic surgeries when tested positive for the said mutations. 360Dx (tiered subscription model) (11/21)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!